These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12781629)

  • 1. Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. II. Spheroid cell spreading inhibition as a new cytotoxic marker.
    Xu J; Ma M; Purcell WM
    Toxicol Appl Pharmacol; 2003 Jun; 189(2):112-9. PubMed ID: 12781629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers.
    Xu J; Ma M; Purcell WM
    Toxicol Appl Pharmacol; 2003 Jun; 189(2):100-11. PubMed ID: 12781628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy metabolism and biotransformation as endpoints to pre-screen hepatotoxicity using a liver spheroid model.
    Xu J; Purcell WM
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):293-302. PubMed ID: 16828827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid.
    Foster AJ; Chouhan B; Regan SL; Rollison H; Amberntsson S; Andersson LC; Srivastava A; Darnell M; Cairns J; Lazic SE; Jang KJ; Petropolis DB; Kodella K; Rubins JE; Williams D; Hamilton GA; Ewart L; Morgan P
    Arch Toxicol; 2019 Apr; 93(4):1021-1037. PubMed ID: 30915487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sub-chronic Xysmalobium undulatum hepatotoxicity investigation in HepG2/C3A spheroid cultures compared to an in vivo model.
    Calitz C; Hamman JH; Fey SJ; Viljoen AM; Gouws C; Wrzesinski K
    J Ethnopharmacol; 2019 Jul; 239():111897. PubMed ID: 31009705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of Albumin Secretion and Metabolic Activity of Cytochrome P450 1A1 of Human Hepatoblastoma HepG2 Cells in Multicellular Spheroids by Controlling Spheroid Size.
    Nishikawa T; Tanaka Y; Nishikawa M; Ogino Y; Kusamori K; Mizuno N; Mizukami Y; Shimizu K; Konishi S; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2017; 40(3):334-338. PubMed ID: 28250275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic profiling of the effects of D-galactosamine in liver spheroids using (1)H NMR and MAS-NMR spectroscopy.
    Bollard ME; Xu J; Purcell W; Griffin JL; Quirk C; Holmes E; Nicholson JK
    Chem Res Toxicol; 2002 Nov; 15(11):1351-9. PubMed ID: 12437325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HepaRG culture in tethered spheroids as an in vitro three-dimensional model for drug safety screening.
    Wang Z; Luo X; Anene-Nzelu C; Yu Y; Hong X; Singh NH; Xia L; Liu S; Yu H
    J Appl Toxicol; 2015 Aug; 35(8):909-17. PubMed ID: 25512232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced hepatotoxicity assessment through encapsulated HepG2 spheroids in gelatin hydrogel matrices: Bridging the gap from 2D to 3D culture.
    Park SY; Koh WG; Lee HJ
    Eur J Pharm Biopharm; 2024 Sep; 202():114417. PubMed ID: 39013493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines.
    Wang K; Shindoh H; Inoue T; Horii I
    J Toxicol Sci; 2002 Aug; 27(3):229-37. PubMed ID: 12238146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Evaluation of Cytochrome P450 3A4 Inhibition and Hepatotoxicity in HepaRG 3-D Spheroids.
    Shin DS; Seo H; Yang JY; Joo J; Im SH; Kim SS; Kim SK; Bae MA
    Int J Toxicol; 2018; 37(5):393-403. PubMed ID: 29923436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of human hepatocyte spheroids without feeder cells for evaluation of hepatotoxicity.
    Ogihara T; Arakawa H; Jomura T; Idota Y; Koyama S; Yano K; Kojima H
    J Toxicol Sci; 2017; 42(4):499-507. PubMed ID: 28717109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction.
    Sun B; Liang Z; Wang Y; Yu Y; Zhou X; Geng X; Li B
    Toxicology; 2024 Jun; 505():153829. PubMed ID: 38740170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic responses of HepG2 cell monolayers and 3D spheroids to selected hepatotoxins.
    Hurrell T; Lilley KS; Cromarty AD
    Toxicol Lett; 2019 Jan; 300():40-50. PubMed ID: 30381255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and functional changes of rat liver spheroids during spheroid formation and maintenance in culture: I. morphological maturation and kinetic changes of energy metabolism, albumin synthesis, and activities of some enzymes.
    Ma M; Xu J; Purcell WM
    J Cell Biochem; 2003 Dec; 90(6):1166-75. PubMed ID: 14635190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorometric assessment of acetaminophen-induced toxicity in rat hepatocyte spheroids seeded on micro-space cell culture plates.
    Sanoh S; Santoh M; Takagi M; Kanayama T; Sugihara K; Kotake Y; Ejiri Y; Horie T; Kitamura S; Ohta S
    Toxicol In Vitro; 2014 Sep; 28(6):1176-82. PubMed ID: 24878114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line.
    Fey SJ; Wrzesinski K
    Toxicol Sci; 2012 Jun; 127(2):403-11. PubMed ID: 22454432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential use of cultured hepatocytes in predicting the hepatotoxicity of xenobiotics.
    Gómez-Lechón MJ; Montoya A; López P; Donato T; Larrauri A; Castell JV
    Xenobiotica; 1988 Jun; 18(6):725-35. PubMed ID: 3420948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.